Mrzljak, Anna; Mikulic, Danko; Busic, Mirela; Vukovic, Jurica; Jadrijevic, Stipislav; Kocman, Branislav
doi : 10.1097/TP.0000000000003453
Transplantation: July 2021 - Volume 105 - Issue 7 - p 1389-1391
Luo, Xunrong
doi : 10.1097/TP.0000000000003826
Transplantation: July 2021 - Volume 105 - Issue 7 - p 1392-1393
Abken, Hinrich
doi : 10.1097/TP.0000000000003614
Transplantation: July 2021 - Volume 105 - Issue 7 - p 1394-1395
empty
doi : 10.1097/TP.0000000000003778
Transplantation: July 2021 - Volume 105 - Issue 7 - p 1396-1397
Piteira, A. Rita; Bofill-R?denas, Ana Maria; Fari?as, Oscar; Tabera, Jaime; Vilarrodona, Anna
doi : 10.1097/TP.0000000000003716
Transplantation: July 2021 - Volume 105 - Issue 7 - p 1398-1402
Young, Katherine; Ali, Hakim Azfar
doi : 10.1097/TP.0000000000003457
Transplantation: July 2021 - Volume 105 - Issue 7 - p 1403-1404
Gaussen, Amaury; Hornby, Laura; Rockl, Gary; O’Brien, Sheila; Delage, Gilles; Sapir-Pichhadze, Ruth; Drews, Steven J.; Weiss, Matthew J.; Lewin, Antoine
doi : 10.1097/TP.0000000000003744
Transplantation: July 2021 - Volume 105 - Issue 7 - p 1405-1422
The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus responsible for the coronavirus disease 2019 (COVID-19) pandemic has raised concerns for programs overseeing donation and transplantation of cells, tissues, and organs (CTO) that this virus might be transmissible by transfusion or transplantation. Transplant recipients are considered particularly vulnerable to pathogens because of immunosuppression, and SARS-CoV-2 is likely to generate complications if contracted.
Kute, Vivek B.; Ray, Deepak S.; Yadav, Dinesh Kumar; Pathak, Vivek; Bhalla, Anil K.; Godara, Suraj; Kumar, Anil; Guleria, Sandeep; Khullar, Dinesh; Thukral, Sharmila; Mondal, Rabi Ranjan Sow; Jain, Manish; Jha, Pranaw Kumar; Hegde, Umapati; Abraham M., Abi; Dalal, Sonal; Patel, Himanshu; Bahadur, Madan M.; Shingare, Ashay; Sharma, Ashish; Kumar Sharma, Raj; Anandh, Urmila; Gulati, Sanjeev; Gumber, Manoj; Siddini, Vishwanath; Deshpande, Rushi; Kaswan, Kamal; Varyani, Umesh; Kakde, Shailesh; Kenwar, Deepesh B.; Shankar Meshram, Hari; Kher, Vijay
doi : 10.1097/TP.0000000000003740
Transplantation: July 2021 - Volume 105 - Issue 7 - p 1423-1432
There is limited current knowledge on feasibility and safety of kidney transplantation in coronavirus disease-19 (COVID-19) survivors.
Cristelli, Marina P.; Viana, Laila A.; Dantas, Marcus T.C.; Martins, Suelen B.S.; Fernandes, Ruan; Nakamura, Monica R.; Santos, Daniel W.C.L.; Taddeo, Julia B.; Azevedo, Vega F.; Foresto, Renato D.; Tedesco-Silva, Helio; Medina-Pestana, Jose
doi : 10.1097/TP.0000000000003751
Transplantation: July 2021 - Volume 105 - Issue 7 - p 1433-1444
Coronavirus disease 2019 (COVID-19) fatality rate is high among kidney transplant recipients. Among survivors, kidney outcomes, seroconversion, and persistence of viral shedding are unexplored.
Theodore, Deborah A.; Greendyke, William G.; Miko, Benjamin; Whittier, Susan; Green, Daniel A.; Shoucri, Sherif; Verna, Elizabeth C.; Zucker, Jason; Sobieszczyk, Magdalena E.; Aaron, Justin G.; Scully, Brian E.; Saiman, Lisa; Pereira, Marcus; Furuya, E. Yoko
doi : 10.1097/TP.0000000000003695
Transplantation: July 2021 - Volume 105 - Issue 7 - p 1445-1448
The optimal duration of transmission-based precautions among immunocompromised patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unknown.
Dery, Kenneth J.; G?rski, Andrzej; Miedzybrodzki, Ryszard; Farmer, Douglas G.; Kupiec-Weglinski, Jerzy W.
doi : 10.1097/TP.0000000000003565
Transplantation: July 2021 - Volume 105 - Issue 7 - p 1449-1458
Bacterio(phages) are bacteria-infecting viruses that employ host translation machinery to replicate, and upon cell lysis, release new particles into the environment. As a result, phages are prey-specific, thus making targeted phage therapy (PT) possible. Indeed, pre- and posttransplant bacterial infections pose a substantial risk to allograft recipients in their clinical course. Moreover, with the increasing threat of antibiotic resistance, the interest in PT as a potential solution to the crisis of multidrug-resistant bacterial pathogens has rapidly grown.
Kardol-Hoefnagel, Tineke; Otten, Henny G.
doi : 10.1097/TP.0000000000003551
Transplantation: July 2021 - Volume 105 - Issue 7 - p 1459-1470
Although solid organ transplant results have improved significantly in recent decades, a pivotal cause of impaired long-term outcome is the development of antibody-mediated rejection (AMR), a condition characterized by the presence of donor-specific antibodies to HLA or non-HLA antigens. Highly HLA-sensitized recipients are treated with desensitization protocols to rescue the transplantation. These and other therapies are also applied for the treatment of AMR.
Karvellas, Constantine J.; Francoz, Claire; Weiss, Emmanuel
doi : 10.1097/TP.0000000000003550
Transplantation: July 2021 - Volume 105 - Issue 7 - p 1471-1481
Liver transplantation (LT) has revolutionized outcomes for cirrhotic patients. Current liver allocation policies dictate patients with highest short-term mortality receive the highest priority, thus, several patients become increasingly ill on the waitlist. Given cirrhosis is a progressive disease, it can be complicated by the occurrence of acute-on-chronic liver failure (ACLF), a syndrome defined by an acute deterioration of liver function associated with extrahepatic organ failures requiring intensive care support and a high short-term mortality. Successfully bridging to transplant includes accurate prognostication and prioritization of ACLF patients awaiting LT, optimizing intensive care support pre-LT, and tailoring immunosuppressive and anti-infective therapies post-LT.
Anguela-Calvet, Laura; Moreno-Gonzalez, Gabriel; Sbraga, Fabrizio; Gonzalez-Costello, Jose; Tsui, Steven; Oliver-Juan, Eva
doi : 10.1097/TP.0000000000003545
Transplantation: July 2021 - Volume 105 - Issue 7 - p 1482-1491
The gold-standard therapy for advanced-stage heart failure is cardiac transplantation. Since the first heart transplant in 1967, the majority of hearts transplanted came from brain death donors. Nevertheless, in recent years, the option of donation after circulatory death (DCD) is gaining importance to increase donor pool. Currently, heart-transplant programs using controlled donation after circulatory death (cDCD) have been implemented in the United Kingdom, Belgium, Australia, United States of America, and, recently, in Spain.
Muller, Elmi; Botha, Francois C. J.; Barday, Zunaid A.; Manning, Kathryn; Chin-Hong, Peter; Stock, Peter
doi : 10.1097/TP.0000000000003485
Transplantation: July 2021 - Volume 105 - Issue 7 - p 1492-1501
HIV-positive patients had been successfully transplanted for the last 15 y and the donor pool had successfully been expanded to also include HIV-positive donors.
Kim, Joseph Y.; Lei, Zhengdeng; Maienschein-Cline, Mark; Chlipala, George E.; Balamurugan, Arumugam; McDiarmid, Sue V.; Azari, Kodi; Yang, Otto O
doi : 10.1097/TP.0000000000003535
Transplantation: July 2021 - Volume 105 - Issue 7 - p 1502-1509
T lymphocyte–mediated acute rejection is a significant complication following solid organ transplantation. Standard methods of monitoring for acute rejection rely on assessing histological tissue damage but do not define the immunopathogenesis. Additionally, current therapies for rejection broadly blunt cellular immunity, creating a high risk for opportunistic infections. There is, therefore, a need to better understand the process of acute cellular rejection to help develop improved prognostic tests and narrowly targeted therapies.
Bhaskaran, Prasanna; Ou, Ruchong; Marasco, Silvana; Perera, Shanaka; Brookes, John; Rosenfeldt, Franklin
doi : 10.1097/TP.0000000000003531
Transplantation: July 2021 - Volume 105 - Issue 7 - p 1510-1515
Donation after circulatory death (DCD) represents an increasing source of organs. However, evaluating the suitability of DCD hearts for transplantation represents a challenge. Contractile function is the ultimate determinant of recovery. We developed a novel technique in an ex vivo rig for the measurement of contractility using intraventricular balloons. We compared this technique with the measurement of lactate metabolism, the current gold standard.
Reese, Shannon R.; Wilson, Nancy A.; Huang, Yabing; Ptak, Lucille; Degner, Kenna R.; Xiang, Ding; Redfield, Robert R.; Zhong, Weixiong; Panzer, Sarah E
doi : 10.1097/TP.0000000000003530
Transplantation: July 2021 - Volume 105 - Issue 7 - p 1516-1529
Transplant glomerulopathy (TG) is a pathological feature of chronic active antibody-mediated rejection (cAMR) and is associated with renal allograft failure. The specific role of B cells in the pathogenesis of TG is unclear.
Bhat, Mamatha; Linares-Cervantes, Ivan; Pasini, Elisa; Patel, Preya; Goto, Toru; Noguchi, Yuki; Mazilescu, Laura; Urbanellis, Peter; Selzner, Markus; Selzner, Nazia
doi : 10.1097/TP.0000000000003476
Transplantation: July 2021 - Volume 105 - Issue 7 - p 1530-1538
Normothermic ex situ liver perfusion (NEsLP) reduces reperfusion injury of donation after circulatory death (DCD) grafts and optimizes graft function. The goal of our study was to elucidate how NEsLP impacts global metabolism in DCD grafts using high-throughput metabolomics.
Ziogas, Ioannis A.; Johnson, Wali R.; Matsuoka, Lea K.; Rauf, Muhammad A.; Thurm, Cary; Hall, Matt; Bacchetta, Matthew; Godown, Justin; Alexopoulos, Sophoclis P
doi : 10.1097/TP.0000000000003414
Transplantation: July 2021 - Volume 105 - Issue 7 - p 1539-1547
Extracorporeal membrane oxygenation (ECMO) can be used to maintain oxygen delivery and provide hemodynamic support in case of circulatory and respiratory failure. Although the role of ECMO has emerged in the setting of adult liver transplantation (LT), data in children are limited. We aimed to describe the characteristics and outcomes of children receiving ECMO support at the time of or following LT.
Parajuli, Sandesh; Aziz, Fahad; Blazel, Justin; Muth, Brenda L.; Garg, Neetika; Mohamed, Maha; Rice, John; Mezrich, Joshua D.; Hidalgo, Luis G.; Mandelbrot, Didier
doi : 10.1097/TP.0000000000003399
Transplantation: July 2021 - Volume 105 - Issue 7 - p 1548-1555
There is limited information about the utility of donor-specific antibody (DSA) against HLA monitoring and the role of protocol kidney biopsy for de novo DSA (dnDSA) in simultaneous liver and kidney (SLK) transplant recipients.
Shaylor, Ruth; Desmond, Fiona; Lee, Dong-Kyu; Koshy, Anoop Ninan; Hui, Victor; Tang, Gia Toan; Fink, Michael; Weinberg, Laurence
doi : 10.1097/TP.0000000000003395
Transplantation: July 2021 - Volume 105 - Issue 7 - p 1556-1563
Blood from deceased organ donors, also known as donor blood (DB), has the potential to reduce the need for packed red blood cells (PRBCs) during liver transplantation (LT). We hypothesized that DB removed during organ procurement is a viable resource that could reduce the need for PRBCs during LT.
Lee, Sung-Gyu; Jeng, Long-Bin; Saliba, Faouzi; Singh Soin, Arvinder; Lee, Wei-Chen; De Simone, Paolo; Nevens, Frederik; Suh, Kyung-Suk; Fischer, Lutz; Jin Joo, Dong; Fung, John; Joh, Jae-Won; Kaido, Toshimi; Grant, David; Meier, Matthias; Rauer, Barbara; Sips, Carole; Kaneko, Shuhei; Levy, Gary
doi : 10.1097/TP.0000000000003394
Transplantation: July 2021 - Volume 105 - Issue 7 - p 1564-1575
Data from 2 randomized liver transplant trials (N = 772; H2304 [deceased donor, n = 488], H2307 [living donor, n = 284]) were pooled to further evaluate the efficacy and safety of everolimus with reduced tacrolimus (EVR + rTAC) versus standard tacrolimus (sTAC) regimen at month 24.
Abu Rmilah, Anan; Fencl, Robert; Watt, Kymberly; Krowka, Michael; Wiesner, Russell; Murray, David; Nyberg, Scott; Leise, Michael
doi : 10.1097/TP.0000000000003390
Transplantation: July 2021 - Volume 105 - Issue 7 - p 1576-1584
The role of MZ phenotype of ? 1 antitrypsin (?1AT) deficiency as a potential cofactor in advanced liver disease arising from other primary causes is not widely understood. In the general population, MZ phenotype accounts for 2%–4% in Europe and 2%–7.1% in North America. The aim of this study was to determine the prevalence of the MZ phenotype among various causes of cirrhosis in the United States in the modern era and its impact on pulmonary function before and after liver transplantation.
Maurel, Pauline; Prémaud, Aurélie; Carrier, Paul; Essig, Marie; Barbier, Louise; Rousseau, Annick; Silvain, Christine; Causse, Xavier; Debette-Gratien, Marilyne; Jacques, Jérémie; Marquet, Pierre; Salamé, Ephrem; Loustaud-Ratti, Véronique
doi : 10.1097/TP.0000000000003384
Transplantation: July 2021 - Volume 105 - Issue 7 - p 1585-1594
Renal failure is predictive of mortality in the early postliver-transplantation period and calcineurin inhibitors toxicity is a main challenge. Our aim is to assess the impact of longitudinal tacrolimus exposure (TLE) and other variables on chronic kidney disease (CKD)-free 1-year-survival.
Robak, Oliver; Kastner, Marie-Theres; Stecher, Carmen; Schneider, Martina; Andreas, Martin; Greinix, Hildegard; Kallay, Enik?; Honsig, Claudia; Steininger, Christoph
doi : 10.1097/TP.0000000000003448
Transplantation: July 2021 - Volume 105 - Issue 7 - p 1595-1602
Allogeneic hematopoietic stem cell transplantation (HSCT) is a potentially curative option for patients with hematologic diseases but is associated with high mortality and morbidity. Cytomegalovirus (CMV) infection is common in HSCT patients and modulates vitamin D metabolism in vitro. We aimed at validating CMV-associated vitamin D metabolism in vivo in HSCT.
Van Rompaey, Winand; Gheysens, Olivier; Deroose, Christophe M.; Verleden, Stijn E.; Vanaudenaerde, Bart M.; Ceulemans, Laurens J.; Van Raemdonck, Dirk E.; Neyrinck, Arne P.; Verleden, Geert M.; Vos, Robin
doi : 10.1097/TP.0000000000003456
Transplantation: July 2021 - Volume 105 - Issue 7 - p 1603-1609
To investigate the diagnostic yield of 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) in lung transplant recipients.
Lee, Sung Kwang; Kim, Do Hyung; Cho, Woo Hyun; Yeo, Hye Ju
doi : 10.1097/TP.0000000000003459
Transplantation: July 2021 - Volume 105 - Issue 7 - p 1610-1614
Right heart failure develops in lung transplantation candidates on extracorporeal membrane oxygenation (ECMO) support and increases mortality. The safety and feasibility of the oxy-right ventricular assist device (oxyRVAD) as a bridge to lung transplantation in severe right heart failure caused by terminal lung disease have not been evaluated.
Moreira, Carla Leal; Hasib Sidiqi, M.; Buadi, Francis K.; Litzow, Mark R.; Gertz, Morie A.; Dispenzieri, Angela; Russell, Stephen J.; Ansell, Stephen M.; Stegall, Mark D.; Prieto, Mikel; Dean, Patrick G.; Nyberg, Scott L.; El Ters, Mireille; Hogan, William J.; Amer, Hatem; Cosio, Fernando G.; Leung, Nelson
doi : 10.1097/TP.0000000000003477
Transplantation: July 2021 - Volume 105 - Issue 7 - p 1615-1624
Experience with sequential hematopoietic stem cell transplant (HSCT) and kidney transplant (KT) is limited.
Dhand, Abhay; Lobo, Stephen A.; Wolfe, Kevin; Feola, Nicholas; Lee, Leslie; Nog, Rajat; Chen, Donald; Glicklich, Daniel; Diflo, Thomas; Nabors, Christopher
doi : 10.1097/TP.0000000000003737
Transplantation: July 2021 - Volume 105 - Issue 7 - p e68-e69
Malleeswaran, Selvakumar; Mohanka, Ravi; Yalakanti, Raghavendra Babu; Patcha, Rajnikanth; Rao, Prashantha S.; Appusamy, Ellango; Sathyanarayanan, Mohan; Shrimal, Anurag; Kumar Kedarisetty, Chandan; Vargese, Joy; Reddy, Mettu Srinivas
doi : 10.1097/TP.0000000000003750
Transplantation: July 2021 - Volume 105 - Issue 7 - p e70-e71
Hogan, Julien; Kwon, Thérésa; Paye-Jaouen, Annabel; Fait, Charlotte; Cointe, Aurélie; Baudouin, Véronique
doi : 10.1097/TP.0000000000003764
Transplantation: July 2021 - Volume 105 - Issue 7 - p e72-e73
Hogan, Julien; Kwon, Thérésa; Paye-Jaouen, Annabel; Fait, Charlotte; Cointe, Aurélie; Baudouin, Véronique
doi : 10.1097/TP.0000000000003774
Transplantation: July 2021 - Volume 105 - Issue 7 - p e74-e75
Odugoudar, Avinash R.; Sharma, Hemant; Hipparagi, Meghana; Devkaran, Bhavesh; Sharma, Ajay
doi : 10.1097/TP.0000000000003703
Transplantation: July 2021 - Volume 105 - Issue 7 - p e76
Patrono, Damiano; Zanierato, Marinella; Avolio, Alfonso Wolfango; Romagnoli, Renato
doi : 10.1097/TP.0000000000003693
Transplantation: July 2021 - Volume 105 - Issue 7 - p e77-e78
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟